Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) filed a Form 8-K with the Securities and Exchange Commission on February 06, 2026, disclosing a material event.
Aspire Biopharma Holdings, Inc.'s stock currently trades at $1.46 with a market capitalization of $5.2M. The Healthcare company's stock moved following the disclosure.